antibacterial DHFR inhibitors (NewBiotics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantibacterial DHFR inhibitors (NewBiotics)
Drug Alias NameNB-3040NB-3178NB-3322
ClassificationSmall molecules
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew Biotics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew Biotics IncKiadis Pharma
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A